1
|
Warmer F, Tanaka K, Xanthopoulos P, Nunami M, Nakata M, Beidler CD, Bozhenkov SA, Beurskens MNA, Brunner KJ, Ford OP, Fuchert G, Funaba H, Geiger J, Gradic D, Ida K, Igami H, Kubo S, Langenberg A, Laqua HP, Lazerson S, Morisaki T, Osakabe M, Pablant N, Pasch E, Peterson B, Satake S, Seki R, Shimozuma T, Smith HM, Stange T, Stechow AV, Sugama H, Suzuki Y, Takahashi H, Tokuzawa T, Tsujimura T, Turkin Y, Wolf RC, Yamada I, Yanai R, Yasuhara R, Yokoyama M, Yoshimura Y, Yoshinuma M, Zhang D. Impact of Magnetic Field Configuration on Heat Transport in Stellarators and Heliotrons. Phys Rev Lett 2021; 127:225001. [PMID: 34889640 DOI: 10.1103/physrevlett.127.225001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 07/30/2021] [Accepted: 09/20/2021] [Indexed: 06/13/2023]
Abstract
We assess the magnetic field configuration in modern fusion devices by comparing experiments with the same heating power, between a stellarator and a heliotron. The key role of turbulence is evident in the optimized stellarator, while neoclassical processes largely determine the transport in the heliotron device. Gyrokinetic simulations elucidate the underlying mechanisms promoting stronger ion scale turbulence in the stellarator. Similar plasma performances in these experiments suggests that neoclassical and turbulent transport should both be optimized in next step reactor designs.
Collapse
Affiliation(s)
- Felix Warmer
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - K Tanaka
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- Kyushu University, Interdisciplinary Graduate School of Engineering Sciences, Plasma and Quantum Science and Engineering, Kasuga, Fukuoka 816-8580, Japan
| | - P Xanthopoulos
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - M Nunami
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
- Nagoya University, Graduate School of Science, Nagoya 464-8603, Japan
| | - M Nakata
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - C D Beidler
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - S A Bozhenkov
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - M N A Beurskens
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - K J Brunner
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - O P Ford
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - G Fuchert
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - H Funaba
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - J Geiger
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - D Gradic
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - K Ida
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - H Igami
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - S Kubo
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- Nagoya University, Graduate School of Science, Nagoya 464-8603, Japan
| | - A Langenberg
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - H P Laqua
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - S Lazerson
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - T Morisaki
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - M Osakabe
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - N Pablant
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543, USA
| | - E Pasch
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - B Peterson
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - S Satake
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - R Seki
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - T Shimozuma
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - H M Smith
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - T Stange
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - A V Stechow
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - H Sugama
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - Y Suzuki
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - H Takahashi
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - T Tokuzawa
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - T Tsujimura
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - Y Turkin
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - R C Wolf
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| | - I Yamada
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - R Yanai
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - R Yasuhara
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - M Yokoyama
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - Y Yoshimura
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
| | - M Yoshinuma
- National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
- SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
| | - D Zhang
- Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
| |
Collapse
|
2
|
Tokuzawa T, Tanaka K, Tsujimura T, Kubo S, Emoto M, Inagaki S, Ida K, Yoshinuma M, Watanabe KY, Tsuchiya H, Ejiri A, Saito T, Yamamoto K. W-band millimeter-wave back-scattering system for high wavenumber turbulence measurements in LHD. Rev Sci Instrum 2021; 92:043536. [PMID: 34243406 DOI: 10.1063/5.0043474] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 04/01/2021] [Indexed: 06/13/2023]
Abstract
A 90 GHz W-band millimeter-wave back-scattering system is designed and installed for measuring electron scale turbulence (k⊥ρs ∼ 40). A metal lens relay antenna is used for in-vessel beam focusing, and a beam diameter of less than 40 mm is achieved in the plasma core region. This antenna can be steered at an angle of 159° ± 6°, which almost covers the plasma radius. The estimated size of the scattering volume is ∼105 mm at the edge and 135 mm at the core, respectively. A 60 m corrugated waveguide is used to achieve a low transmission loss of ∼8 dB. A heterodyne detection system for millimeter-wave circuits with probing power modulation can distinguish the scattered signal from background noise.
Collapse
Affiliation(s)
- T Tokuzawa
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - K Tanaka
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - T Tsujimura
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - S Kubo
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - M Emoto
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - S Inagaki
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - K Ida
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - M Yoshinuma
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - K Y Watanabe
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Tsuchiya
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - A Ejiri
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - T Saito
- Research Center for Development of Far-Infrared Region, University of Fukui, Bunkyo 3-9-1, Fukui 910-8507, Japan
| | - K Yamamoto
- Research Center for Development of Far-Infrared Region, University of Fukui, Bunkyo 3-9-1, Fukui 910-8507, Japan
| |
Collapse
|
3
|
Ishihara T, Sotomi Y, Tsujimura T, Okuno S, Iida O, Kobayashi T, Hamanaka Y, Omatsu T, Higuchi Y, Mano T. Impact of diabetes mellitus on the early phase arterial healing after drug-eluting stent implantation: a multicenter coronary angioscopic study. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Diabetes mellitus (DM) is a strong risk factor for major cardiac and cerebrovascular events. In particular, coronary artery disease with DM is often complicated with complex lesions. Drug-eluting stents (DES) are mainly used for these lesions, and dual-antiplatelet therapy (DAPT) has been used to prevent stent thrombosis. Early arterial healing after DES implantation may enable short DAPT strategy. However, the impact of DM on the arterial healing in the early phase has not been elucidated to date.
Purpose
We evaluated the arterial healing in the early phase after DES implantation using coronary angioscopy (CAS) and compared the findings between DM and non-DM patients.
Methods
This study was a multicenter retrospective observational study. We analyzed CAS findings of 337 lesions from 270 patients which were evaluated 3 to 5 months after DES implantation. Patients were divided into two groups: DM (149 lesions in 118 patients) versus non-DM groups (188 lesions in 152 patients). We assessed neointimal coverage (NIC) grades (maximum, minimum and dominant), thrombus adhesion and maximum yellow color of plaque underneath the stent. NIC was graded as follows: grade 0, stent struts were not covered; grade 1, stent struts were covered by thin layer; grade 2, stent struts were buried under neointima. Yellow color was graded as follows: grade 0, white; grade 1, light yellow; grade 2, yellow; grade 3, intensive yellow.
Results
Minimum NIC coverage grade was lower in DM group than in non-DM group (P=0.002, Figure), while maximum and dominant NIC coverage grades were similar between them (P=0.94 and P=0.59, respectively). Thrombus adhesion (44.3% versus 38.8%, P=0.32) and maximum yellow color grade (P=0.78) were also similar between DM and non-DM groups. Even after the adjustment by the confounding factors such as follow-up duration and primary disease of acute coronary syndrome, DM was an independent factor predicting grade 0 of minimum NIC (odds ratio [OR] 1.83 [95% confidence interval 1.11–3.03], P=0.019).
Conclusion
DM patients showed less covered struts than non-DM patients 3 to 5 months after DES implantation, suggesting that the recent ultra-short DAPT strategy might not be easily applicable to DM patients.
Minimum neointimal coverage grade
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Sotomi
- Osaka Police Hospital, Department of Cardiology, Osaka, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kobayashi
- Osaka Police Hospital, Department of Cardiology, Osaka, Japan
| | - Y Hamanaka
- Osaka Police Hospital, Department of Cardiology, Osaka, Japan
| | - T Omatsu
- Osaka Police Hospital, Department of Cardiology, Osaka, Japan
| | - Y Higuchi
- Osaka Police Hospital, Department of Cardiology, Osaka, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
4
|
Tsujimura T, Iida O, Takahara M, Yamauchi Y, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Yokoi H, Miyamoto A, Mano T. P4704The efficacy of intravascular ultrasound for patients with peripheral artery diseases presenting aorto-iliac artery disease. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The use of intravascular ultrasound (IVUS) promotes better clinical outcomes for intervention in complex lesions. However, the data demonstrating whether use of IVUS improves primary patency following stenting for aorto-iliac lesions in patients with peripheral artery disease (PAD) are limited.
Purpose
The purpose of the current study was to investigate the impact of IVUS use on primary patency 12 months after stent implantation for aorto-iliac lesions.
Methods
We analyzed a clinical database of the OMOTENASHI registry (Observational prospective Multicenter registry study on Outcomes of peripheral arTErial disease patieNts treated by AngioplaSty tHerapy in aortoIliac artery), registering symptomatic PAD patients (Rutherford category 2, 3, or 4) undergoing endovascular therapy for aorto-iliac lesions between January 2014 and April 2016 in Japan. The current study analyzed 803 patients who underwent self-expandable stent implantation at 61 centers with the institutional volume known. The primary endpoint was 12-month restenosis, defined as ≥50% stenosis on computed tomography or angiography, or a peak systolic velocity ratio ≥2.5 on duplex ultrasound. When treatment strategies, endovascular procedures and clinical outcomes were compared between the patients treated with IVUS use and those treated without IVUS use, the propensity score matching was performed to minimize the inter-group difference in baseline characteristics.
Results
A total of 545 patients (67.9%) underwent IVUS-supported stent implantation. Patients treated with IVUS use had a lower prevalence of regular dialysis, whereas they had a higher prevalence of TASC II class D and chronic total occlusion. In patients treated with IVUS use, carbon dioxide contrast agent were more often used, and 0.035-inch guidewire was less frequently selected. Implanted stents in these patients were longer and smaller in diameter. The propensity score matching extracted 138 pairs, with no remarkable intergroup difference in baseline characteristics. Procedure time ≤1 hour was less frequent in patients treated with IVUS use; their radiation time was longer. Endovascular strategies, as well as postoperative medication were not significantly different between patients with and without IVUS use. The 12-month restenosis risk was not significantly different between patients with and without IVUS use (10.2% [6.9 to 14.9%] versus 10.3% [5.4 to 18.6%], P=0.99).
Conclusion
IVUS use in aorto-iliac stenting for patients with PAD was not associated with primary patency at 12 months.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Takahara
- Osaka University Graduate School of Medicine, Department of Metabolic Medicine, Osaka, Japan
| | - Y Yamauchi
- Takatsu General Hospital, Cardiovascular Center, Kawasaki, Japan
| | - Y Shintani
- Shin-Koga Hospital, Department of Cardiology, Fukuoka, Japan
| | - T Sugano
- Yokohama City University Hospital, Department of Cardiovascular Medicine, Yokohama, Japan
| | - Y Yamamoto
- Iwaki Kyoritsu General Hospital, Department of Cardiovascular Medicine, Fukushima, Japan
| | - D Kawasaki
- Morinomiya Hospital, Cardiovascular Division, Department of Internal Medicine, Osaka, Japan
| | - H Yokoi
- Fukuoka Sanno Hospital, Cardiovascular Center, Fukuoka, Japan
| | - A Miyamoto
- Takatsu General Hospital, Cardiovascular Center, Kawasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
5
|
Hata Y, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Mano T. P4711The prognostic impact of infrapopliteal arterial calcification on wound healing in patients with critical limb ischemia. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Critical limb ischemia (CLI) is the most progressed manifestation of peripheral artery disease. Although patients with CLI commonly complicate with severely calcified lesions in infrapopliteal lesions, the prognostic impact of infrapopliteal arterial calcification on wound healing in patients with CLI has not been systematically studied.
Purpose
The aim of current study was to elucidate the prognostic impact of infrapopliteal arterial calcification on wound healing in CLI undergoing endovascular therapy (EVT).
Methods
This study enrolled 639 CLI patients with tissue loss (age 74±10 years, male 62%, diabetes 69%, hemodialysis 57%, Rutherford class 5 77%, class 6 23%) primarily treated with EVT for the infrapopliteal lesions between April 2010 and December 2015. Arterial calcification was assessed by high intensity fluoroscopy and classified into 3 groups as follows; 1) none, 2) unilateral and 3) bilateral calcification. The primary outcome measure was complete wound healing. The predictors of the outcome were evaluated by Cox proportional hazards regression analysis.
Results
During a mean follow-up period of 22±19 months, 1-year wound healing rate were 59.0%. In Kaplan-Meier analysis, 1-year wound healing rate was worse in patients with bilateral calcification than in those with unilateral or none calcification (Figure, 46.2% versus 55.1% versus 67.8%, P<0.001). After multivariate analysis, the predictors of wound healing were non-ambulatory status (hazard ratio (HR) 0.67 [95% confidential interval (CI) 0.53–0.85], P=0.001) and bilateral calcification (HR 0.75 [95% CI 0.47–0.98], versus none or unilateral calcification, P=0.036).
Figure 1
Conclusion
Infrapopliteal Arterial calcification as well as non-ambulatory status was associated with wound healing in patients with CLI.
Collapse
Affiliation(s)
- Y Hata
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
6
|
Tsujimura T, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Okuno S, Matsuda Y, Mano T. P3386Angioscopic comparison between polymer-free biolimus A9-coated stent and durable polymer drug-eluting stent 10 months after the implantation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Polymer-free biolimus A9-coated stent (DCS) has currently emerged as expected better arterial healing compared to durable polymer drug-eluting stent (DP-DES). However, superiority of DCS on arterial healing over DP-DES has not been well elucidated using intracoronary images.
Methods
This study examined 288 stents in 224 patients with de novo coronary artery lesions. We angioscopically compared 55 DCS from 35 patients with 233 DP-DES from 189 patients 10±2 months after the implantation. We assessed thrombus adhesion, which is a marker of incomplete re-endothelialization. Dominant neointimal coverage (NIC) grade, heterogeneity of NIC and maximum yellow color of plaque underneath the stent were also evaluated. Neointimal coverage was graded as follows: grade 0, stent struts exposed; grade 1, struts bulged into the lumen, although covered; grade 2, struts embedded by the neointima, but translucent; grade 3, struts fully embedded and invisible. NIC was judged as heterogeneous when differences in the NIC grade became apparent. Yellow plaque was graded as follows: grade 0, white; grade 1, light yellow; grade 2, yellow; grade 3, intensive yellow.
Results
Thrombus adhesion was similar between DCS and DP-DES (29% versus 23%, P=0.32). Dominant NIC was greater in DCS than in BP-DES (P<0.001), while NIC was more heterogeneous in DCS than in BP-DES (P=0.001, Figure). Maximum yellow color of stented segment was similar between DCS and DP-DES (P=0.09).
Conclusion
DCS provided similar thrombus adhesion to DP-DES, which suggested similar re-endothelialization 10 months after implantation. However, DCS showed thick and heterogeneous NIC compared to DP-DES. The specific feature of polymer-free and Biolimus A9 would cause the difference, and further investigation is necessary to evaluate the longer-term safety and efficacy.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
7
|
Kanda T, Masuda M, Shizuta S, Kobori A, Inoue K, Kaitani K, Kurotobi T, Morishima I, Nakazawa Y, Tsujimura T, Iida O, Asai M, Mano T. P1035Factors associated with quality-of-life improvement after catheter ablation of atrial fibrillation: insights from the Kansai Plus Atrial Fibrillation (KPAF) registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Improving the quality of life (QoL) is one of the main purposes of catheter ablation (CA) of persistent atrial fibrillation (AF). Factors associated with QoL improvement after CA of AF patients have not been clarified. The Kansai Plus Atrial Fibrillation (KPAF) Registry is a multi-center registry enrolling more than 5,000 consecutive patients undergoing the first radiofrequency catheter ablation of AF.
Purpose
The aim of this study was to investigate the QoL change after AF ablation and its associated factors.
Methods
A total of 2030 patients in whom the QoL score was assessed before and one year after the ablation were enrolled from the KPAF registry (age 64±10 years, 75% male, paroxysmal 66%, CHADS2 score 1.1±1.1). The QoL was evaluated using the AF specific QoL evaluation method (AFQLQ), which scores the patient QoL within a range of 0–98 points.
Results
Overall, catheter ablation showed a significant increase in the AFQLQ score (68±19 vs. 86±13 points, P<0.01). AF recurrence was observed in 372 cases (18%) during a 1-year follow-up period. A multivariate analysis showed that AF recurrence, symptomatic AF, long AF duration, high preprocedural heart rate (>110 bpm) and small left atrial diameter were independent predictors of a QoL improvement defined as a >10% score increase.
Multivariate analysis
Conclusions
CA of AF significantly improved the QoL. AF recurrence was one of the strong factors associated with QoL improvement. Symptomatic AF, long AF duration, high preprocedural heart rate and small left atrial diameter were independent predictors of QoL improvement.
Collapse
Affiliation(s)
- T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Shizuta
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| | - A Kobori
- Kobe City Medical Center General Hospital, Division of Cardiology, Kobe, Japan
| | - K Inoue
- Sakurabashi-Watanabe Hospital, Cardiovascular center, Osaka, Japan
| | - K Kaitani
- Otsu Red Cross Hospital, Division of Cardiology, Otsu, Japan
| | - T Kurotobi
- Shiroyama Hospital, Cardiovascular center, Habikino, Japan
| | - I Morishima
- Ogaki Municipal Hospital, Department of cardiology, Ogaki, Japan
| | - Y Nakazawa
- Shiga University of Medical Science, Department of Cardiovascular Medicine,Heart Rhythm Center, Shiga, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
8
|
Kanda T, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Matsuda Y, Okuno S, Mano T. P1916A novel echo-guided approach of cryoballoon ablation without using contrast medium. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Pulmonary vein isolation (PVI) using cryoballoon requires contrast medium injection for the confirmation of appropriate venous occlusion. However, some patients have contra-indications against contrast use such as allergy for contrast medium, bronchial asthma or renal dysfunction. We hypothesized that intra-cardiac echocardiographic observation of microbubble leakage after saline injection from the cryoballoon lumen can be used as a maker of incomplete venous occlusion.
Purpose
The aim of this study was to assess the effect of echo-guided approach using saline injection on the acute clinical outcomes as well as the amount of contrast medium.
Methods
Twenty consecutive patients with paroxysmal atrial fibrillation (AF) were studied. They had any reason to avoid using contrast medium. Plain CT scan was performed in all cases to understand the anatomical features. Intra-cardiac echocardiography was used in all cases to guide transseptal puncture and to confirm pulmonary-vein occlusion. Procedural results and clinical outcomes were compared with patients who were performed by the conventional method (n=279).
Results
In all study patients, we could perform PVI without using contrast medium. A total of 2 patients required touch-up ablation using radiofrequency ablation catheter. The procedure time (85±23 vs 86±27 min, P=0.84), the dose of radiation exposure (108±78 vs. 140±133 mmGy/m2, P=0.29), and ratio of requiring touch-up ablation (5% vs 4%, P=0.81) were similar between the study group and the reference group. There was no significant difference in the AF-free survival rate (73% vs. 76%, P=0.79) during a follow-up period of 14±6 months.
Images of ICE
Conclusion
Echo-guided approach using saline infusion was effective and less invasive in terms of reduction of contrast use.
Collapse
Affiliation(s)
- T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
9
|
Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Hata Y, Uematsu H, Sato Y, Mano T. P6241Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Biodegradable polymer drug-eluting stent (BP-DES) has been developed to improve clinical outcomes after percutaneous coronary intervention (PCI) for patients presenting coronary artery disease (CAD). Although BP-DES showed non-inferior safety and efficacy to durable polymer DES (DP-DES) in several randomized clinical trials, hemodialysis (HD) patients, who have been well known as high risk population for adverse events, were excluded in the most of trials. Therefore, there are limited data comparing the clinical outcomes between BP-DES and DP-DES in HD patients with CAD after PCI.
Purpose
The purpose of this study was to investigate clinical outcomes in HD patients after BP-DES implantation compared with those after DP-DES implantation.
Methods
We retrospectively analyzed 234 HD patients (male 74%, mean age 71±10 years) undergoing PCI for 404 lesions with 472 DESs (71 patients for 138 lesions with 170 BP-DESs [91 Ultimaster and 79 Synergy] and 163 HD patients for 266 lesions with 302 DP-DESs [219 Xience, 53 Promus and 30 Resolute]) from 2011 to 2017. Two-year clinical outcomes were compared between BP-DES group and DP-DES group. The primary outcome measure was the incidence of target lesion revascularization (TLR), while the secondary outcome measures were the occurrence of cardiac death (CD), stent thrombosis (ST), myocardial infraction (MI), target vessel revascularization (TVR), non-TVR and major adverse cardiac event (MACE) defined as a composite of CD, MI, and TVR. Outcome measures were estimated by the Kaplan-Meier method and the differences between BP-DES group and DP-DES group were assessed by the log-rank test. We also conducted Cox's proportional hazard model to identify predictors for TLR occurrence.
Results
Baseline patient and lesion characteristics were similar between the two groups. The two-year incidence of TLR was not significantly different between BP-DES group and DP-DES group (14.1% vs. 22.2%, p=0.391). The two-year incidences of CD (17.3% vs. 17.5%, p=0.381), ST (0% vs. 3.9%, p=0.133), MI (4.2% vs. 5.8%, p=0.965), TVR (21.3% vs. 27.5%, p=0.586), non-TVR (26.1% vs. 31.3%, p=0.439) and MACE (41.1% vs. 42.6%, p=0.526) were also not different between the two groups. After multivariate analysis, diabetes mellitus (hazard ratio 1.97; 95% confidence interval 1.03–3.78, p=0.004) was independently associated with TLR occurrence in HD patients.
Two-year clinical outcomes of HD patient
Conclusions
At two-year follow-up after PCI, BP-DES had comparable safety and efficacy profiles to DP-DES in HD patients presenting CAD.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- S Okuno
- Kansai Rosai Hospital, Amagasaki, Japan
| | | | - O Iida
- Kansai Rosai Hospital, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Amagasaki, Japan
| | | | - Y Matsuda
- Kansai Rosai Hospital, Amagasaki, Japan
| | - Y Hata
- Kansai Rosai Hospital, Amagasaki, Japan
| | - H Uematsu
- Kansai Rosai Hospital, Amagasaki, Japan
| | - Y Sato
- Kansai Rosai Hospital, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Amagasaki, Japan
| |
Collapse
|
10
|
Tokuzawa T, Tsuchiya H, Tsujimura T, Emoto M, Nakanishi H, Inagaki S, Ida K, Yamada H, Ejiri A, Watanabe KY, Oguri K, Akiyama T, Tanaka K, Yamada I. Microwave frequency comb Doppler reflectometer applying fast digital data acquisition system in LHD. Rev Sci Instrum 2018; 89:10H118. [PMID: 30399698 DOI: 10.1063/1.5035118] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Accepted: 06/25/2018] [Indexed: 06/08/2023]
Abstract
We succeeded in increasing the radial observation points of the microwave frequency comb Doppler reflectometer system from 8 to 20 (or especially up to 45) using the high sampling rate of 40 GS/s digital signal processing. For a new acquisition system, the estimation scheme of the Doppler shifted frequency is constructed and compared with the conventional technique. Also, the fine radial profile of perpendicular velocity is obtained, and it is found that the perpendicular velocity profile is consistent with the E × B drift velocity one.
Collapse
Affiliation(s)
- T Tokuzawa
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Tsuchiya
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - T Tsujimura
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - M Emoto
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Nakanishi
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - S Inagaki
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - K Ida
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - H Yamada
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - A Ejiri
- Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8561, Japan
| | - K Y Watanabe
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - K Oguri
- Department of Energy Engineering and Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
| | - T Akiyama
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - K Tanaka
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| | - I Yamada
- National Institutes of Natural Sciences, National Institute for Fusion Science, Toki 509-5292, Japan
| |
Collapse
|
11
|
Magara J, Watanabe M, Tsujimura T, Hamdy S, Inoue M. Cold thermal oral stimulation produces immediate excitability in human pharyngeal motor cortex. Neurogastroenterol Motil 2018; 30:e13384. [PMID: 29856098 DOI: 10.1111/nmo.13384] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Accepted: 04/24/2018] [Indexed: 02/08/2023]
Abstract
BACKGROUND Current strategies of swallowing therapy include facilitation of swallowing initiation by sensory modulation. Although thermal tactile oral stimulation is a common method to treat dysphagic patients to improve swallowing movement, little is known about the possible mechanisms. This study is aimed to investigate whether thermal oral (tongue) stimulation can modulate the cortico-pharyngeal neural motor pathway in humans. METHODS Eighteen healthy volunteers participated and were intubated with an intraluminal catheter for recording pharyngeal electromyography. Each participant underwent baseline transcranial magnetic stimulation (TMS) cortico-pharyngeal motor evoked potential (MEP) measurements bilaterally. MEPs were then measured during thermal stimulation over the dorsal tongue, applied using the Peltier device at three different temperatures; 45°C, 37°C, and 15°C, in a pre-ordered manner. Each of the three temperatures was given twice with a 5-min resting time between each trial. Averaged MEP amplitude changes were analyzed using ANOVA and post-hoc t-tests. KEY RESULTS Two-way repeated measures ANOVA with factors of Temperature × Trial in amplitude of MEP demonstrated a significant effect of Temperature both in the stronger (F2,34 = 5.775, P = .007) and weaker (F2,34 = 4.771, P = .017) pharyngeal hemispheres. Subsequent post-hoc tests showed the significant increase in pharyngeal MEPs at 15° compared to 37° in both hemispheres (P < .05). CONCLUSIONS & INFERENCES Cold oral stimulation was able to induce significant changes in pharyngeal cortical excitability, demonstrating evidence for a sensorimotor interaction between oral and pharyngeal cortical areas.
Collapse
Affiliation(s)
- J Magara
- Division of Dysphagia Rehabilitation, Niigata University, Niigata, Japan
| | - M Watanabe
- Division of Dysphagia Rehabilitation, Niigata University, Niigata, Japan
| | - T Tsujimura
- Division of Dysphagia Rehabilitation, Niigata University, Niigata, Japan
| | - S Hamdy
- GI Sciences, School of Medical Sciences, University of Manchester, MAHSC, Salford, UK
| | - M Inoue
- Division of Dysphagia Rehabilitation, Niigata University, Niigata, Japan
| |
Collapse
|
12
|
Hata Y, Iida O, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Takahara M, Mano T. P1633Further risk stratification by systemic factors in WIfI (Wound, Ischemia, and foot Infection classification system) stage 4 but not in stage 1-3 in critical limb ischemia. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Y Hata
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Takahara
- Osaka University Graduate School of Medicine, Department of Metabolic Medicine, Osaka, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
13
|
Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1201The association with p-wave duration and the prevalence of left atrial low-voltage areas. Europace 2018. [DOI: 10.1093/europace/euy015.683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ohashi
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - H Kawai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - A Tsuji
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Hata
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
14
|
Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1169Severity of chronic kidney disease predicts the prevalence of left atrial low-voltage areas. Europace 2018. [DOI: 10.1093/europace/euy015.654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Y Matsuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Masuda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - M Asai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - O Iida
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okamoto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ishihara
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - K Nanto
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Kanda
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Tsujimura
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - S Okuno
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Ohashi
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - H Kawai
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - A Tsuji
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - Y Hata
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| | - T Mano
- Kansai Rosai Hospital, Cardiovascular Center, Amagasaki, Japan
| |
Collapse
|
15
|
Kuroda A, Kondo N, Fukuda A, Nakamichi T, Nakamura A, Hashimoto M, Takuwa T, Matsumoto S, Tsujimura T, Takashi K, Hasegawa S. P3.09-009 Fourteen Cases Study of 5 Year Survivors of Malignant Pleural Mesothelioma Following Extrapleural Pneumonectomy. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
16
|
Hiroshima K, Wu D, Yusa T, Ozaki D, Koh E, Sekine Y, Haba R, Washimi K, Nabeshima K, Tsujimura T. P2.09-006 FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Hashimoto M, Nakamichi T, Fukuda A, Kuroda A, Takuwa T, Matsumoto S, Kondo N, Tsujimura T, Hasegawa S. P2.09-007 Pleural Biopsy in Patients Suspected of Malignant Pleural Mesothelioma Consecutive 377 Cases. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
18
|
Iizumi T, Magara J, Tsujimura T, Inoue M. Effect of body posture on chewing behaviours in healthy volunteers. J Oral Rehabil 2017; 44:835-842. [DOI: 10.1111/joor.12555] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/23/2017] [Indexed: 11/29/2022]
Affiliation(s)
- T. Iizumi
- Division of Dysphagia Rehabilitation; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
- Department of Communication Disorders; School of Rehabilitation Sciences; Health Sciences University of Hokkaido, Ishikari-Tobetsu; Hokkaido Japan
| | - J. Magara
- Division of Dysphagia Rehabilitation; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - T. Tsujimura
- Division of Dysphagia Rehabilitation; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - M. Inoue
- Division of Dysphagia Rehabilitation; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| |
Collapse
|
19
|
Kanda T, Fujita M, Iida O, Masuda M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Sunaga A, Uematsu M, Mano T. P3367A novel index of left ventricular stiffness predicting clinical outcome in patients with heart failure. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
Okuno S, Ishihara T, Iida O, Fujita M, Masuda M, Okamoto S, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Ohashi T, Kawai H, Tsuji A, Hata Y, Mano T. P1387Three-year clinical outcomes of hemodialysis patients with coronary artery disease after second-generation drug-eluting stent implantation. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Creely AJ, Ida K, Yoshinuma M, Tokuzawa T, Tsujimura T, Akiyama T, Sakamoto R, Emoto M, Tanaka K, Michael CA. Novel analysis technique for measuring edge density fluctuation profiles with reflectometry in the Large Helical Device. Rev Sci Instrum 2017; 88:073509. [PMID: 28764512 DOI: 10.1063/1.4993437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
A new method for measuring density fluctuation profiles near the edge of plasmas in the Large Helical Device (LHD) has been developed utilizing reflectometry combined with pellet-induced fast density scans. Reflectometer cutoff location was calculated by proportionally scaling the cutoff location calculated with fast far infrared laser interferometer (FIR) density profiles to match the slower time resolution results of the ray-tracing code LHD-GAUSS. Plasma velocity profile peaks generated with this reflectometer mapping were checked against velocity measurements made with charge exchange spectroscopy (CXS) and were found to agree within experimental uncertainty once diagnostic differences were accounted for. Measured density fluctuation profiles were found to peak strongly near the edge of the plasma, as is the case in most tokamaks. These measurements can be used in the future to inform inversion methods of phase contrast imaging (PCI) measurements. This result was confirmed with both a fixed frequency reflectometer and calibrated data from a multi-frequency comb reflectometer, and this method was applied successfully to a series of discharges. The full width at half maximum of the turbulence layer near the edge of the plasma was found to be only 1.5-3 cm on a series of LHD discharges, less than 5% of the normalized minor radius.
Collapse
Affiliation(s)
- A J Creely
- MIT Plasma Science and Fusion Center, Cambridge, Massachusetts 02139, USA
| | - K Ida
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - M Yoshinuma
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - T Tokuzawa
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - T Tsujimura
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - T Akiyama
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - R Sakamoto
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - M Emoto
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - K Tanaka
- National Institute for Fusion Science, Toki, Gifu, Japan
| | - C A Michael
- Plasma Research Lab, Australian National University, Canberra, Australia
| |
Collapse
|
22
|
Avila JG, Tsujimura T, Oberholzer J, Churchill T, Salehi P, Shapiro AMJ, Lakey JRT. Improvement of Pancreatic Islet Isolation Outcomes Using Glutamine Perfusion during Isolation Procedure. Cell Transplant 2017; 12:877-881. [DOI: 10.3727/000000003771000228] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
During procurement, isolation, and transplantation, islets are exposed to high levels of oxidative stress triggering a variety of signaling pathways that can ultimately lead to cell death. Glutamine is an important cellular fuel and an essential precursor for the antioxidant glutathione. The aim of this study was to examine the role of intraductal glutamine administration in facilitating recovery of isolated rat islets from pancreases subjected to a clinically relevant period of warm ischemia. Islets were isolated in Sprague-Dawley (SD) rats (n= 18 per group). Pancreata in groups 1 and 2 were procured immediately while groups 3 and 4 were subjected to 30-min warm ischemia. Groups 2 and 4 were treated intraductally with 5 mM glutamine prior to pancreatectomy. Exposure to 30-min warm ischemia significantly reduced islet yield [groups 1 & 2 (nonischemia): 503 ± 29 islets/rat vs. groups 3 & 4 (ischemia): 247 ± 26 islets/rat; p < 0.05]. Intraductal glutamine treatment significantly improved islet yield when pancreata were subjected to 30-min warm ischemia [144 ± 16 islets/rat without glutamine (group 3) vs. 343 ± 36 islets/rat with glutamine (group 4), p < 0.05]. Glutamine also significantly improved islet viability (values were 50 ± 4% in group 4 vs. 27 ± 3% in group 3, p < 0.05). Similarly, glutathione (reduced) levels were significantly elevated in both glutamine-treated groups; however, this increase was greatest in tissues exposed to ischemia (2.76 ± 0.04 nmol/mg protein in group 4 vs. 1.66 ± 0.04 nmol/mg protein in group 3, p < 0.05). Intraductal glutamine administration considerably improves the islet yield, viability, and augments endogenous glutathione levels in pancreata procured after a clinically relevant period of ischemia. Intraductal administration of glutamine at the time of digestive enzyme delivery into the harvested pancreas may represent a simple yet effective tool to improve islet yields in clinical isolations.
Collapse
Affiliation(s)
- J. G. Avila
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
- Department of Surgery, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - T. Tsujimura
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
- Department of Surgery, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - J. Oberholzer
- Department of Surgery, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - T. Churchill
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - P. Salehi
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - A. M. James Shapiro
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
- Department of Surgery, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | - J. R. T. Lakey
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
- Department of Surgery, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| |
Collapse
|
23
|
Doi H, Matsumoto S, Odawara S, Shikata T, Tanooka M, Kitajima K, Takada Y, Fujiwara M, Tsujimura T, Kamikonya N, Hirota S. Pravastatin Reduces Radiation-Induced Damage to Normal Tissues. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Doi H, Odawara S, Matsumoto S, Shikata T, Suzuki H, Kato T, Tarutani K, Kosaka K, Inoue H, Tanooka M, Takada Y, Tsujimura T, Kamikonya N, Hirota S. 609 Pravastatin protects normal intestinal epithelium and normal lung from radiation-induced cell death. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30345-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Odawara S, Doi H, Tsujimura T, Shikata T, Suzuki H, Kosaka K, Inoue H, Tanooka M, Takada Y, Niwa Y, Fujiwara M, Kamikonya N, Hirota S. Polaprezinc Protects Intestinal Epithelium From Radiation-Induced Damage in Mice. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
26
|
Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, Kondo Y, Sato A, Hasegawa Y, Tsujimura T, Sekido Y. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. Oncogene 2013; 34:73-83. [DOI: 10.1038/onc.2013.528] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2013] [Revised: 10/22/2013] [Accepted: 10/25/2013] [Indexed: 12/20/2022]
|
27
|
Doi H, Kamikonya N, Takada Y, Fujiwara M, Miura H, Inoue H, Tanooka M, Nakamura T, Tsujimura T, Hirota S. 2033 POSTER Radiation-induced Rectal Toxicity in Rats on Low-dose Aspirin Therapy. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)70991-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
28
|
Doi H, Kamikonya N, Takada Y, Fujiwara M, Miura H, Inoue H, Tanooka M, Shikata T, Tsujimura T, Hirota S. 2032 POSTER Radiation-induced Microangiopathy in the Rectum Using an Animal Experimental Model. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)70990-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Tanaka F, Yoneda K, Kondo N, Hashimoto M, Takuwa T, Matsumoto S, Hasegawa S, Okumura Y, Tsujimura T, Fukuoka K, Nakano T. Circulating tumor cell (CTC) as a clinical marker in malignant pleural mesothelioma (MPM). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10572] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
30
|
Yoneda K, Tanaka F, Kondo N, Orui H, Hashimoto M, Takuwa T, Matsumoto S, Okumura Y, Sato A, Tsujimura T, Tsubota N, Kuribayashi K, Fukuoka K, Nakano T, Hasegawa S. Circulating endothelial cell (CEC), a surrogate of tumor angiogenesis, as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10577] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
31
|
Matsumoto S, Yoneda K, Orui H, Hashimoto M, Takuwa T, Okumura Y, Kondo N, Torii I, Tsujimura T, Fukuoka K, Nakano T, Tanaka F, Hasegawa S. Diagnosis of malignant pleural mesothelioma: Comparison between pleural effusion cytology and pleural biopsy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Doi H, Kamikonya N, Takada Y, Fujiwara M, Tsuboi K, Miura H, Inoue H, Tanooka M, Nakamura T, Shikata T, Tsujimura T, Hirota S. 914 poster LATE RECTAL TOXICITY FOLLOWING IRRADIATION IN RATS. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71036-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Yoneda K, Tanaka F, Hashimoto M, Matsumoto S, Kondo N, Hasegawa S, Tsujimura T, Fukuoka K, Nakano T. Circulating tumor cells (CTCs) and endothelial cells (CECs) in the diagnosis of malignant pleural mesothelioma (MPM): A single-institutional prospective study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e18024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
34
|
Mukubou H, Tsujimura T, Sasaki R, Yoshida K, Suzuki Y, Hori Y, Ku Y. Significance of Autophagy Induced by Gemcitabine, Radiotherapy, and the Combination of Them against Pancreatic Adenocarcinoma In Vitro and In Vivo. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
35
|
Fujiwara Y, Yoshikawa R, Tao L, Tsujimura T, Sasako M. Stemness signature of BMI1 and clinical outcome in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.4572] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4572 Background: The polycomb group (PcG) family BMI1, acting downstream of the hedgehog (Hh) pathway, plays an essential role in the self-renewal of hematopoietic, neural, and intestinal stem cells, and is dysregulated in many types of cancer. Our recent report has demonstrated that Gli-1 nuclear expression indicative of Hh signalling activation can predict very poorer prognosis of esophageal squamous cell carcinomas (ESCCs)(Br J Cancer 2008). As data were not available on the clinical role of BMI1 expression, we analyzed whether it could be also used to predict disease progression and prognosis in ESCC patients undergoing neoadjuvant chemoradiotherapy (CRT). Methods: BMI1, Gli-1, and p16INK4A expressions were evaluated in 78 ESCC patients by immunohistochemical staining. All patients underwent preoperative chemoradiotherapy; 40 Gy irradiation plus FP (5- FU and CDDP) regimen. Results: In total, 24 out of 78 patients (30.8%) showed BMI1 positive expression. All Gli- 1 nuclear positive cancers expressed BMI1. There was no significant correlation between p16INK4A expression and BMI1 expression. Overall survival (OS) was significantly correlated with the absence of BMI1 expression. The patients with BMI1-positive cancers showed significantly poorer prognoses than those without (mean disease-free survival (DFS) time 16.8 vs 71.2 months, P<0.005; mean OS time 21.8 vs 76.6 months, P<0.001). Conclusions: We demonstrated that BMI1 expression indicative of PcG protein chromatin silencing pathway activation was significantly correlated with esophageal cancer recurrence and poor prognosis after CRT, and that it was not inversely correlated with the presence of the downstream target p16INK4A. These findings suggest that the stemness signature including components of Hh and PcG pathways might be involved in promoting cancer regrowth and progression after CRT, and is thus a potential prognostic biomarker and rational therapeutic target for attacking the “more aggressive” cancer cells causing recurrence. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | | | - L. Tao
- Hyogo College of Medicine, Hyogo, Japan
| | | | - M. Sasako
- Hyogo College of Medicine, Hyogo, Japan
| |
Collapse
|
36
|
Yoneda K, Tanaka F, Hashimoto M, Takuwa T, Matsumoto S, Okumura Y, Kondo N, Hasegawa S, Tsujimura T, Fukuoka K, Nakano T. Circulating tumor cells (CTCs) and endothelial cells (CECs) in the diagnosis of malignant pleural mesothelioma (MPM): A single institutional prospective study. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e22107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e22107 Background: Circulating tumor cell (CTC), a surrogate of distant metastasis, and circulating endothelia cell (CEC), a surrogate of angiogenesis, are potentially useful in the diagnosis of malignant tumors. Following a promising result of our preliminary study showing the diagnostic value of CTC/CEC in malignant pleural mesothelioma (MPM)(Tanaka F, et al. ASCO 2008), we conducted a prospective study. Methods: Patients (pts), who presented at our institute with suspicion or diagnosis of MPM, were eligible in the study. CTCs and CECs in peripheral blood (7.5mL and 4.0mL, respectively) were captured and quantitatively evaluated with the “CellSearch” system without knowledge of clinical characteristics of patients. Results: A total of 92 pts were enrolled into the study, and the final diagnosis was MPM in 68, other malignant tumors in 7, and non-malignant diseases in 17 pts ( Table ). CTC was positive (CTC-count, 1 or more per 7.5mL of the peripheral blood) in 35%(24/68) of MPM pts (range of CTC-count, 0–27 cells/7.5 mL). Among non-malignant pts, 3 pts (18%) showed a positive-CTC, but no patient showed 2 or more CTCs in 7.5mL of the peripheral blood. The mean CEC-count (/4.0mL) was significantly higher in MPM pts than in non-malignant pts (105.1 versus 40.2; p=0.047). When the cut-off value of CEC-count for the diagnosis of MPM was defined as 50(cells/4.0mL), the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of malignant diseases were 66%, 70%, 93%, and 26%, respectively. There was no correlation between CTC-positivity and clinical stage of MPM pts, but was a trend of increase in the mean CEC-count along with tumor progression (mean CEC-count for stage I, II, III, and IV pts: 63.0, 82.4, 95.6, and 116.7, respectively). Conclusions: CTC and CEC are useful clinical markers in the diagnosis of MPM. [Table: see text] No significant financial relationships to disclose.
Collapse
Affiliation(s)
- K. Yoneda
- Hyogo College of Medicine, Hyogo, Japan
| | - F. Tanaka
- Hyogo College of Medicine, Hyogo, Japan
| | | | - T. Takuwa
- Hyogo College of Medicine, Hyogo, Japan
| | | | | | - N. Kondo
- Hyogo College of Medicine, Hyogo, Japan
| | | | | | | | - T. Nakano
- Hyogo College of Medicine, Hyogo, Japan
| |
Collapse
|
37
|
Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer 2008; 98:1670-4. [PMID: 18475300 PMCID: PMC2391133 DOI: 10.1038/sj.bjc.6604361] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
The zinc finger protein glioma-associated oncogene homologue 1 (Gli-1) is a critical component of the Hedgehog (Hh) signalling pathway, which is essential for morphogenesis and stem-cell renewal, and is dysregulated in many cancer types. As data were not available on the role of Gli-1 expression in oesophageal cancer progression, we analysed whether it could be used to predict disease progression and prognosis in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy (CRT). Among 69 patients with histologically confirmed oesophageal squamous cell carcinomas (ESCCs), 25 showed a pathological complete response after preoperative CRT. Overall survival (OS) was significantly associated with lymph-node metastasis, distant metastasis, and CRT, and was further correlated with the absence of both Gli-1 nuclear expression and residual tumour. All patients with Gli-1 nuclear expression (10.1%) had distant or lymph-node metastasis, and six out of seven died within 13 months. Furthermore, patients with Gli-1 nuclear-positive cancers showed significantly poorer prognoses than those without (disease-free survival: mean DFS time 250 vs 1738 months, 2-year DFS 0 vs 54.9%, P=0.009; OS: mean OS time 386 vs 1742 months, 2-year OS 16.7 vs 54.9%, P=0.001). Our study provides the first evidence that Gli-1 nuclear expression is a strong and independent predictor of early relapse and poor prognosis in ESCC after CRT. These findings suggest that Hh signal activation might promote cancer regrowth and progression after CRT.
Collapse
Affiliation(s)
- R Yoshikawa
- Department of Genetics, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Fujiwara Y, Yoshikawa R, Koishi K, Matsumoto T, Kojima S, Hashimoto-Tamaoki T, Tsujimura T. Cyclooxygenase-2 (COX-2) expression after neoadjuvant chemoradiotherapy and response to platinum/taxanes containing adjuvant chemotherapy in esophageal cancer. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15032 Background: Cyclooxygenase-2 (COX-2) is an inducible enzyme linked to the conversion of arachidonic acid to prostaglandin H2. Recent reports have indicated that tumor with high COX-2 expression are refractory to chemotherapy and associated with poor outcome. In this study, we investigated the relationship of COX-2 expressive tumor with response to platinum/taxanes chemotherapy and its clinical significance in esophageal cancer patients undergoing chemoradiotherapy (CRT). Methods: COX-2 expressions were evaluated in 53 patients with histologically confirmed esophageal squamous cell carcinoma (ESCC) undergoing preoperative CRT, by immunohistochemical staining. Preoperative CRT was consisted of 5-FU plus cisplatin chemotherapy and total 40Gy irradiation. Platinum/taxanes treatment was chosen for the first-line adjuvant chemotherapy. Results: 17 patients showed a pathological CR in the resected specimens. COX-2 expression was absent from 14 tumors (38.9%), and positive in other 22 tumors (61.1%). Recurrences were found in 15 patients in COX-2 (+) group, and in 5 patients in COX-2 (-) group (p=0.0874). There were significant associations between OS and effect of CRT, Lymph nodes metastasis, and distant metastasis (p=0.00004, p=0.0095, and p=0.0277, respectively). COX-2 expression showed a significant prognostic value for DFS (p=0.0401), but not for the OS with univariate analysis. Intriguingly, platinum/taxanes chemotherapy succeeded in improving OS in the recurrence group (p=0.0188). Conclusions: Our data suggests that positive COX-2 expression after CRT correlates with early recurrence of ESCC patient after CRT and possible prognostic factor in disease-free survival. Adjuvant chemotherapy after surgery is much more influential for prognosis in the ESCC patients than the status of COX-2 expression after CRT. COX-2 status might provide a preferable choice for platinum/taxanes in postoperative adjuvant setting. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- Y. Fujiwara
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - R. Yoshikawa
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - K. Koishi
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - T. Matsumoto
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - S. Kojima
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - T. Hashimoto-Tamaoki
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| | - T. Tsujimura
- Hyogo College of Medicine, Nishinomiya-city, Japan; Hyogo Colege of Medicine, Nishinomiya-city, Japan
| |
Collapse
|
39
|
Sakai T, Li S, Tanioka Y, Goto T, Tanaka T, Matsumoto I, Tsujimura T, Fujino Y, Suzuki Y, Kuroda Y. Intraperitoneal injection of oxygenated perfluorochemical improves the outcome of intraportal islet transplantation in a rat model. Transplant Proc 2007; 38:3289-92. [PMID: 17175252 DOI: 10.1016/j.transproceed.2006.10.183] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2006] [Indexed: 10/23/2022]
Abstract
A 50% to 75% early graft loss upon engraftment has been suggested to in intraportal islet transplantation (IPIT). Hypoxia in the portal vein contributes to graft loss in immediately posttransplantation. Herein we examined the effect on the outcome of IPIT of intraperitoneal oxygenated perfluorochemical (PFC) as an oxygen carrier. Isolated Lewis rat islets were transplanted into the portal vein of a chemically induced diabetic syngeneic rat. First, 1500 IEQ was determined to be the optimal dose in this study. When oxygenated PFC (group 1) was intraperitoneally injected following IPIT of 1500 IEQ, the success rate of transplantation was 5/6, in contrast to 1/6 when PFC with no oxygen was injected (group 2) and 1/6 in IPIT without PFC, respectively. The area under the glucose profile curve on intraperitoneal glucose tolerance tests on posttransplant day 28 in group 1 was significantly smaller than that for group 2. In conclusion, intraperitoneal oxygenated PFC improved the outcome of IPIT.
Collapse
Affiliation(s)
- T Sakai
- Department of Gastroenterological Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Sugihara A, Nakasho K, Yamada N, Nakagomi N, Tsujimura T, Terada N, Tsuji M. Neuroendocrine differentiation of periodic-acid Schiff and Alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer. Scand J Gastroenterol 2004; 39:795-800. [PMID: 15513370 DOI: 10.1080/00365520410005775] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
A case of a Borrmann type 2 advanced gastric cancer with endocrine differentiation is described. Histologically, the cancer was either composed of cells arranged in a tubular pattern or formed solid nests of various sizes. The tubular pattern was composed of a moderately differentiated tubular adenocarcinoma. The histology showed partial carcinoid tumor-like features. Cancer cells inside solid nests had a signet-ring cell-like appearance. Periodic-acid Schiff (PAS) staining was positive in the cytoplasm of a few of the cells found in the tubular pattern and in the mucus in some lumens and on the apical surface of cells in some lumens, but PAS did not stain cancer cells in the solid nests. Neither cancer cells nor mucus in the lumens were stained with alcian blue. All cancer cells were strongly positive for Grimelius silver stain, and most of the cancer cells stained positively for chromogranin A. Electron microscopic examination showed electron dense neuroendocrine granules in the cytoplasm of cancer cells. Cancer cells were stained positively for pancytokeratin, cytokeratin 8/18 and carcinoembryonic antigen. Muc 1 mucin glycoprotein staining was positive along the cell surfaces of cancer cells, but Muc 2, 5AC and 6 stainings were negative, although Muc 3 stained positively in the cytoplasm of a few cancer cells. The present case is a gastric tubular adenocarcinoma with Muc 1-positive, neutral- and acid mucin-negative signet-ring cell-like cells, which is associated with neuroendocrine differentiation.
Collapse
Affiliation(s)
- A Sugihara
- Dept. of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
| | | | | | | | | | | | | |
Collapse
|
41
|
Tsujimura T, Kuroda Y, Avila J, Kin T, Shapiro AM, Lakey J. THE INFLUENCE OF PANCREAS PRESERVATION ON HUMAN ISLET ISOLATION OUTCOMES: IMPACT OF THE TWO-LAYER METHOD. Transplantation 2004. [DOI: 10.1097/00007890-200407271-00941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
42
|
Tsujimura T, Kuroda Y, Avila JG, Kin T, Churchill TA, Shapiro AMJ, Lakey JRT. Resuscitation of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Transplant Proc 2003; 35:2461-2. [PMID: 14611986 DOI: 10.1016/j.transproceed.2003.08.026] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
A two-layer cold storage method (TLM) allows sufficient oxygen delivery to pancreata during preservation and resuscitates the viability of ischemically damaged pancreata. This study determined the effect of additional preservation of ischemically damaged human pancreata by the TLM before islet isolation. Human pancreata were procured from cadaveric organ donors and preserved by the TLM for 3.2 +/- 0.5 hours (mean +/- SEM) at 4 degrees C after 11.1 +/- 0.9 hours of cold storage in University of Wisconsin solution (UW) (TLM group), or by cold UW alone for 11.0 +/- 0.3 hours (UW group). Islet isolations of all pancreata were performed using the Edmonton protocol. Islet recovery and in vitro function of isolated islets were significantly increased in the TLM group compared with the UW group. In the metabolic assessment of human pancreata, ATP levels were significantly increased after the TLM preservation. This study showed that additional short-term preservation by the TLM resuscitates the viability of ischemically damaged human pancreata before islet isolation, leading to improvements in islet recovery and in vitro function of isolated islets.
Collapse
Affiliation(s)
- T Tsujimura
- Surgical-Medical Research Institute, Department of Surgery, University of Alberta, Edmonton, Canada
| | | | | | | | | | | | | |
Collapse
|
43
|
Avila JG, Tsujimura T, Oberholzer J, Churchill T, Salehi P, Shapiro AMJ, Lakey JRT. Improvement of pancreatic islet isolation outcomes using glutamine perfusion during isolation procedure. Cell Transplant 2003; 12:877-81. [PMID: 14763507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023] Open
Abstract
During procurement, isolation, and transplantation, islets are exposed to high levels of oxidative stress triggering a variety of signaling pathways that can ultimately lead to cell death. Glutamine is an important cellular fuel and an essential precursor for the antioxidant glutathione. The aim of this study was to examine the role of intraductal glutamine administration in facilitating recovery of isolated rat islets from pancreases subjected to a clinically relevant period of warm ischemia. Islets were isolated in Sprague-Dawley (SD) rats (n = 18 per group). Pancreata in groups 1 and 2 were procured immediately while groups 3 and 4 were subjected to 30-min warm ischemia. Groups 2 and 4 were treated intraductally with 5 mM glutamine prior to pancreatectomy. Exposure to 30-min warm ischemia significantly reduced islet yield [groups 1 & 2 (nonischemia): 503 +/- 29 islets/rat vs. groups 3 & 4 (ischemia): 247 +/- 26 islets/rat; p < 0.05]. Intraductal glutamine treatment significantly improved islet yield when pancreata were subjected to 30-min warm ischemia [144 +/- 16 islets/rat without glutamine (group 3) vs. 343 +/- 36 islets/rat with glutamine (group 4), p < 0.05]. Glutamine also significantly improved islet viability (values were 50 +/- 4% in group 4 vs. 27 +/- 3% in group 3, p < 0.05). Similarly, glutathione (reduced) levels were significantly elevated in both glutamine-treated groups; however, this increase was greatest in tissues exposed to ischemia (2.76 +/- 0.04 nmol/mg protein in group 4 vs. 1.66 +/- 0.04 nmol/mg protein in group 3, p < 0.05). Intraductal glutamine administration considerably improves the islet yield, viability, and augments endogenous glutathione levels in pancreata procured after a clinically relevant period of ischemia. Intraductal administration of glutamine at the time of digestive enzyme delivery into the harvested pancreas may represent a simple yet effective tool to improve islet yields in clinical isolations.
Collapse
Affiliation(s)
- J G Avila
- Surgical-Medical Research Institute, University of Alberta, 1074 Dentistry/Pharmacy Centre, Edmonton, Canada T6G 2N8
| | | | | | | | | | | | | |
Collapse
|
44
|
Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, Hayashi S, Okamura H, Akedo H, Terada N. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 2002; 30:901-8. [PMID: 12052461 DOI: 10.1016/s8756-3282(02)00722-6] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The effect of interleukin (IL)-18 on osteoclastic bone-resorbing activity was investigated in vitro. Osteoclast-enriched cells, about 70% of which were tartrate-resistant acid phosphatase (TRAP)-positive, were cultured on dentine slices, and then the total volume of resorption pits on each dentine slice was measured as bone-resorbing activity. When the effects of IL-18 alone at 1, 10, 100, and 1000 ng/mL were examined, bone-resorbing activity was significantly reduced only at 1000 ng/mL, by about 50%. However, IL-18 plus IL-12 (10 ng/mL each) reduced bone-resorbing activity by about 70%, whereas IL-12 alone had no significant effect. When the concentration of interferon (IFN)-gamma in the medium was measured, IL-18 or IL-12 was found to increase it slightly, and the combination of these two cytokines synergistically increased it. The inhibitory effect of the combination of the two cytokines was completely abolished by the addition of an anti-IFN-gamma neutralizing antibody to the medium, but IFN-gamma by itself did not inhibit osteoclastic bone resorption. IL-18 alone or in combination with IL-12 did not affect the number of TRAP-positive cells in culture of osteoclast-enriched cells. Osteoclasts prepared from osteoclast-enriched cells expressed mRNAs of IL-18 receptor, MyD88, and cathepsin K. Furthermore, IL-18 receptor protein was detected on the cell surface of osteoclasts. The present results indicate that the combination of IL-18 and IL-12 synergistically inhibits osteoclastic bone-resorbing activity, suggesting that IFN-gamma participates in the mechanism underlying this inhibition.
Collapse
Affiliation(s)
- N Yamada
- First Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Ikeda R, Aiyama S, Tsujimura T, Okamoto K. Developmental changes in the fine structure and histochemical properties of mucous cells in the parotid gland of the infant Japanese macaque. Arch Histol Cytol 2001; 64:545-53. [PMID: 11838714 DOI: 10.1679/aohc.64.545] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Mucous cells have been known to occur in the terminal portions of the parotid gland in a few species of mammals during a limited period of their development. The aim of this study was to examine the occurrence and features of mucous cells in the parotid gland of the infant Japanese macaque. Light microscopy revealed that mucous cells in the macaque parotid gland were present in the terminal clusters and acini at postnatal day 15, were less prevalent at day 30, and continued to decrease in number over 3 months. Mucous cells were no longer recognized in the parotid gland in 6-month-old macaques. Electron microscopy showed that the mucous cells contained electron-lucent secretory granules and bipartite or tripartite secretory granules. By 3 months of age, there was a scarcity of mucous cells and a concomitant increase in transitional cells. These transitional cells were intermediate in structure between mucous and serous cells, and contained three types of granules: electron-lucent, bipartite or tripartite, and electron-dense. None of the cells showed apoptotic figures. Lectin histochemistry indicated that the mucous cells in the early postnatal period had sugar residues identical in nature to those seen in the granules from mature serous cells in the glands of 3-month-old macaques. Immunohistochemistry using an antibody against human alpha-amylase showed a weakly positive reactivity in the secretory granules of the mucous cells, starting from day 15. In the transitional cells, the electron-dense granules showed a stronger immunoreactivity than either the electron-lucent granules or the heterogeneously structured granules. These results suggest that the secretory granules of mucous cells have characteristics in common with those of serous cells, and that during the transitional period the mucous granules change from the initial electron-lucent to hetorogenous forms, finally becoming the electron-dense granules. The mucous cells in the parotid gland of the juvenile Japanese macaque are therefore suggested to be converted into serous cells.
Collapse
Affiliation(s)
- R Ikeda
- Department of Histology, The Nippon Dental University School of Dentistry at Tokyo, Japan.
| | | | | | | |
Collapse
|
46
|
Fujino Y, Suzuki Y, Tsujimura T, Takahashi T, Tanioka Y, Tominaga M, Ku Y, Kuroda Y. Possible role of heat shock protein 60 in reducing ischemic-reperfusion injury in canine pancreas grafts after preservation by the two-layer method. Pancreas 2001; 23:393-8. [PMID: 11668209 DOI: 10.1097/00006676-200111000-00010] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Abstract
INTRODUCTION Recently, results of the clinical application of the two-layer method have shown the morphologic quality of the human pancreas grafts after reperfusion to be excellent, although ischemia-reperfusion injury is related to early graft loss in pancreas transplantation. However, some reports have indicated that heat shock proteins (HSPs) have important functions in response to the stress-related events. AIM To examine whether the two-layer method reduced ischemia-reperfusion injury in a canine pancreas autotransplantation model by investigating the expression of HSPs. METHODOLOGY There were three experimental groups in which dogs received segmental autografts after preservation by the two-layer method using University of Wisconsin solution (UW) (group 1), simple storage in UW (group 2) for 24 hours, or no preservation (group 3). RESULTS In group 1, pancreatic tissue perfusions were high, and pancreatic exocrine functions were well preserved after 1, 2, and 4 hours of reperfusion with low incidence of graft pancreatitis or vessel thrombosis compared with that in group 2. Moreover, ATP rapidly recovered, and HSP 60 was strongly enhanced after reperfusion in group 1. On the other hand, ATP recovery and the enhancement of HSP 60 were weak after reperfusion in group 2. CONCLUSION The two-layer method reduced ischemia-reperfusion injury compared with UW simple storage in canine pancreas autotransplantation with a strong expression of HSP 60.
Collapse
Affiliation(s)
- Y Fujino
- First Department of Surgery, Kobe University Faculty of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Sugihara A, Yamada N, Tsujimura T, Iwasaki T, Yamashita K, Takagi Y, Tsuji M, Terada N. Castration induces apoptosis in the male accessory sex organs of Fas-deficient lpr and Fas ligand-deficient gld mutant mice. In Vivo 2001; 15:385-90. [PMID: 11695234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
The role of the Fas ligand-Fas system in castration-induced apoptosis in the epithelia of the ventral prostate (VP), seminal vesicle (SV), coagulating gland (CG) and epididymis (Ep) was investigated using lpr/lpr, and gld/gld mutant mice which are deficient in Fas and Fas ligand, respectively. The degree of apoptosis in the epithelium was quantitatively estimated by an apoptotic index (a percentage of apoptotic cells). The weights (mg/10 g body weight) of the VP, SV, CG and Ep of lpr/lpr and gld/gld mice were similar to those of normal +/+ mice and castration decreased the weights of the VP, SV, CG and Ep in these three kinds of mice to similar levels. Castration also increased the apoptotic indices in these organs reaching maximum on days 2-6 after castration. There was no significant difference in the apoptotic index of these organs among +/+, lpr/lpr and gld/gld mice on days 0-8 after castration. Agarose gel electrophoresis of DNAs extracted from the VP, SV, CG and Ep of +/+, lpr/lpr and gld/gld mice on day 4 after castration showed a ladder pattern. The present results suggest that the Fas ligand-Fas system plays little role in castration-induced apoptosis in the mouse male accessory sex organs such as the VP, SV, CG and Ep.
Collapse
Affiliation(s)
- A Sugihara
- Department of Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Minami T, Fukui K, Morita Y, Kondo S, Ohmori Y, Kanayama S, Taenaka N, Yoshikawa K, Tsujimura T. A case of squamous cell carcinoma of the pancreas with an initial symptom of tarry stool. J Gastroenterol Hepatol 2001; 16:1077-9. [PMID: 11595080 DOI: 10.1046/j.1440-1746.2001.2574b.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
|
49
|
Kitanaka J, Kitanaka N, Tsujimura T, Terada N, Takemura M. Histamine N-methyltransferase regulates histamine-induced phosphoinositide hydrolysis in guinea pig cerebellum. Neurosci Lett 2001; 308:5-8. [PMID: 11445272 DOI: 10.1016/s0304-3940(01)01947-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We report here that the dose-response curve of the histamine-stimulated phosphoinositide hydrolysis in the guinea pig cerebellar slices was shifted to the left when the slices were pretreated with SKF 91488 (100 microM), a specific inhibitor of histamine N-methyltransferase (HMT). In contrast, the pretreatment of the cerebellar slices with aminoguanidine (100 microM - 1 mM), an inhibitor of diamine oxidase, had no effect on histamine-induced phosphoinositide hydrolysis. HMT mRNA was expressed abundantly in cerebellum, especially in Purkinje cells. These observations suggest that HMT regulates histaminergic neurotransmission in guinea pig cerebellum more predominantly than diamine oxidase in histamine degradation.
Collapse
Affiliation(s)
- J Kitanaka
- Department of Pharmacology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, 663-8501, Hyogo, Japan
| | | | | | | | | |
Collapse
|
50
|
Kojima T, Ishiko O, Ichimura T, Nishimura S, Sumi T, Ueda J, Tsujimura T, Shimura K. The usefulness and limits of magnetic resonance imaging in the differential diagnosis of pelvic tumors. Oncol Rep 2001; 8:867-9. [PMID: 11410800 DOI: 10.3892/or.8.4.867] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Three cases of benign pelvic tumors are presented (2 leiomyomas and 1 fibroma). All three tumors were suspected of being malignant neoplasms because they were visualized as heterogeneous high signal intensity on T2-weighted images, and thus they were difficult to diagnose preoperatively. One of the leiomyomas was located in the retroperitoneum and had been misdiagnosed as an ovarian tumor. All three tumors exhibited secondary myxoid changes, these changes may have been responsible for the high signal intensity on the T2-weighted MR images. Since benign tumors sometimes mimic malignant tumors on MR images, exploratory laparotomy is essential to make a definitive diagnosis.
Collapse
Affiliation(s)
- T Kojima
- Department of Obstetrics and Gynecology, Sumitomo Hospital, 5-3-20 Nakanoshima, Kita-ku, Osaka 530-0005, Japan.
| | | | | | | | | | | | | | | |
Collapse
|